Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers

Author： Miura M. Kagaya H. Tada H. Sagae Y. Satoh S. Habuchi T. Suzuki T.

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.35, Iss.5, 2005-05, pp. : 479-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole

By Miura M. Kagaya H. Tada H. Uno T. Yasui-Furukori N. Tateishi T. Suzuki T.

Xenobiotica, Vol. 36, Iss. 1, 2006-01 ,pp. : 95-102

Informa Healthcare

Access to resources Recommend Favorite

Effects of CYP2C19 polymorphism on the pharmacokinetics of lansoprazole and its main metabolites in healthy Chinese subjects

By Zhang Dan Wang Xiaolin Yang Man Wang Guocai Liu Huichen

Xenobiotica, Vol. 41, Iss. 6, 2011-06 ,pp. : 511-517

Informa Healthcare

Access to resources Recommend Favorite

Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration

By Miura Masatomo Motoyama Satoru Hinai Yudai Niioka Takenori Endo Masahiro Hayakari Makoto Ogawa Jun-ichi

Xenobiotica, Vol. 40, Iss. 9, 2010-09 ,pp. : 630-636

Informa Healthcare

Access to resources Recommend Favorite

Serum Cystatin C Levels in Renal Transplant Recipients

By Krishnamurthy N.

Indian Journal of Clinical Biochemistry, Vol. 26, Iss. 2, 2011-04 ,pp. : 120-124

Springer Publishing Company

Access to resources Recommend Favorite

Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes

By Tu J.-H. Hu D.-L. Dai L.-L. Sun Y. Fan L. Zhang M. Tan Z.-R. Chen Y. Li Z. Zhou H.-H.

Xenobiotica, Vol. 40, Iss. 6, 2010-06 ,pp. : 393-399

Informa Healthcare

Access to resources Recommend Favorite